Commercialization of COVID-19 Vaccines, Treatments, and Tests: Implications for Access and Coverage

With the depletion of the federal-purchased supply of COVID-19 vaccines, treatments and tests following the end of the public health emergency, this resource provides an overview of the implications of these changes for access to people covered by Medicare, Medicaid and private insurance, as well as those who are uninsured.

Leave a Reply

Your email address will not be published. Required fields are marked *